Company page

Resmed Inc.

Resmed Inc. (Ticker: RMD) is a public company operating in the American market, specializing in innovative solutions for sleep and respiratory disorders. With a market capitalization of approximately $28.3 billion, Resmed is committed to improving patient outcomes through advanced technology and products. The company focuses on providing high-quality devices and cloud-connected solutions to enhance the management of chronic obstructive pulmonary disease and sleep apnea.

RMD:NYSEUpdated August 31, 2026
Resmed Inc. logo
Ticker
RMD:NYSE
Asset type
Stock
Market cap
$34.67B
Sector
Health Technology
Industry
Medical Specialties
Exchange
NYSE
Currency
USD